Report in today's Australian Life Scientist
http://www.biotechnews.com.au/index.php?id=1494073475&eid=-2
============================================
Biotech briefs
Imugene to commercialise, Viralytics to present, Solbec eyes expansion
Dylan Bushell-Embling 09/09/2008 15:07:00
Animal health company Imugene [ASX: IMU] has reported small losses this financial year, but has made progress towards commercialising two products.
The company recorded a net loss of $1.9 million, and a net cash outflow of $1.2 million, and the company said it has developed two animal vaccines with healthy earning potential.
The first, a vaccine for porcine reproductive and respiratory syndrome (PPRS), has been tested and the company is currently seeking licensees. Imugene will soon undergo final trials of the second, a vaccine for coccidiosis in chickens, which will be tested to determine the optimal dosage.
- Forums
- ASX - By Stock
- IMU
- prrs vaccine proves highly effective
prrs vaccine proves highly effective, page-5
Featured News
Add IMU (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.001(2.04%) |
Mkt cap ! $356.9M |
Open | High | Low | Value | Volume |
4.9¢ | 4.9¢ | 4.8¢ | $424.8K | 8.751M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
69 | 8622849 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 1925890 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
68 | 8206183 | 0.048 |
47 | 5236997 | 0.047 |
44 | 3057430 | 0.046 |
62 | 5148745 | 0.045 |
14 | 2201381 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 1925890 | 9 |
0.050 | 5499815 | 23 |
0.051 | 4492903 | 11 |
0.052 | 2536519 | 9 |
0.053 | 2257540 | 9 |
Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
The Watchlist
AHK
ARK MINES LIMITED
Ben Emery, Executive Director
Ben Emery
Executive Director
SPONSORED BY The Market Online